Rheumatic Heart Disease in Immigrant Men: The Cardiac Legacy of Childhood Strep

There is a cardiac condition that has been nearly eliminated in high-income countries but remains one of the most common causes of acquired heart disease in much of the world. It is caused by a throat infection most children recover from without lasting damage. But in communities where antibiotics were unavailable, healthcare was inaccessible, or streptococcal infection was recurrent and unrecognized, the immune response to that infection left a permanent scar on the heart.

Rheumatic heart disease is the long-term cardiac consequence of acute rheumatic fever, itself a complication of untreated Group A streptococcal pharyngitis (strep throat). It damages the heart’s valves, most commonly the mitral valve, producing structural changes that can take decades to manifest clinically but that eventually cause heart failure, stroke, atrial fibrillation, and death if unrecognized and unmanaged.

Men who grew up in South Asia, Sub-Saharan Africa, Latin America, the Pacific Islands, and parts of the Middle East and Eastern Europe may be carrying this legacy today, often without knowing it. They immigrated to high-income countries as adults, sought care in systems that have not seen rheumatic heart disease as an endemic problem for generations, and present with unexplained exertional dyspnea or palpitations that no one thinks to connect to a throat infection from thirty years earlier.

Group A Streptococcus and the Heart

Group A Streptococcus (GAS), or Streptococcus pyogenes, is the bacterium responsible for strep throat, a common bacterial pharyngitis. In most settings with access to medical care, GAS pharyngitis is treated with a short course of antibiotics, the infection resolves, and there are no lasting consequences.

Without antibiotic treatment, or in settings with high rates of streptococcal transmission and repeated reinfection, the immune response to GAS can become pathological. Certain GAS serotypes produce antigenic proteins that share molecular similarity with proteins in human heart tissue, joints, brain, and skin. This “molecular mimicry” causes the immune system, in mounting a response to GAS, to also attack the host’s own tissues.

The resulting condition is acute rheumatic fever (ARF), a multi-organ inflammatory syndrome that develops 2 to 4 weeks after untreated strep pharyngitis. The Jones criteria, which guide the clinical diagnosis of ARF, require evidence of a preceding streptococcal infection plus a combination of major criteria (carditis, polyarthritis, chorea, erythema marginatum, subcutaneous nodules) and minor criteria (fever, elevated inflammatory markers, prolonged PR interval on electrocardiogram).

Carditis, meaning inflammation of the heart and specifically of the valves, is the most clinically significant feature of ARF. It occurs in approximately 50 to 70 percent of first episodes of ARF and is the feature that causes permanent cardiac damage.

How Valve Damage Develops

During acute rheumatic carditis, the valve leaflets, which are delicate fibrous structures that open and close to direct blood flow through the heart, become inflamed and edematous. Fibrin deposits form on the leaflet edges. In mild cases or single episodes of ARF, this inflammation resolves completely with no permanent damage.

With repeated episodes of ARF, which occur when GAS reinfection is not prevented, the cumulative inflammatory injury to the valve leaflets results in fibrosis, thickening, calcification, and fusion of the leaflet tips (commissures). This process is rheumatic heart disease.

The mitral valve is the most frequently damaged valve in RHD, affected in approximately 65 to 70 percent of cases, either alone or in combination with aortic valve involvement. The aortic valve is affected in isolation in about 25 percent of cases. The tricuspid and pulmonary valves are less commonly involved.

The primary lesion of rheumatic mitral valve disease is mitral stenosis: the valve opening narrows progressively as the leaflets thicken and fuse, restricting blood flow from the left atrium to the left ventricle. Over time, the left atrium dilates under the elevated pressure required to push blood through the narrowed valve. This atrial dilation is a substrate for atrial fibrillation and promotes blood stasis with risk of thrombus formation and embolic stroke.

The progression from initial valve damage to hemodynamically significant stenosis is typically measured in decades. A man who experienced rheumatic fever at age 8 may not develop exertional symptoms from his mitral stenosis until age 35 to 45. This latent period is precisely why so many immigrant men present to healthcare systems in high-income countries with previously undiagnosed advanced valve disease.

The Global Burden of RHD

The global epidemiological picture of rheumatic heart disease is stark. The World Heart Federation estimates that approximately 40 million people worldwide live with RHD, with more than 300,000 deaths attributable to the disease annually. The vast majority of this burden falls on low- and middle-income countries.

Prevalence studies using echocardiographic screening, which is more sensitive than clinical examination, have found RHD rates of 20 to 30 per 1,000 schoolchildren in some parts of sub-Saharan Africa, 5 to 10 per 1,000 in parts of South Asia, and similar rates in Pacific Island populations. These rates dwarf the residual prevalence of echocardiographically detected RHD in high-income countries, where disease acquired in childhood is now rare.

The regions contributing the largest numbers of immigrants to high-income countries, including sub-Saharan Africa, South Asia, Latin America, and Southeast Asia, are precisely the regions with the highest RHD burden. This demographic intersection means that the immigrant population in countries like the United States, the United Kingdom, Canada, and Australia carries a burden of RHD that the receiving healthcare systems are not systematically equipped to detect.

Why RHD Is Missed in Healthcare Systems of High-Income Countries

Physicians trained in high-income settings are not trained to have a high clinical suspicion for RHD. The disease has been effectively eliminated in these countries through improved living conditions, reduced household crowding, and ready access to antibiotics for strep throat. The clinical gestalt for RHD, the pattern-recognition system that makes clinicians think of a diagnosis automatically, does not exist in these settings the way it does in, for example, a pediatric cardiology ward in Nairobi or Dhaka.

A middle-aged man who presents to a primary care physician in Chicago or London with unexplained exertional dyspnea is far more likely to be evaluated initially for coronary artery disease, hypertension, or COPD than for mitral stenosis from rheumatic heart disease. His immigration history and childhood experience in an RHD-endemic region may not be elicited, and even if it is, the clinical significance may not be recognized.

The result is diagnostic delay. Men with significant mitral stenosis may wait years from symptom onset to echocardiographic diagnosis. By the time the diagnosis is made, they may have developed significant atrial fibrillation, left atrial thrombus, or even an embolic stroke.

How RHD Presents in Adult Immigrant Men

The clinical presentation of RHD in adult men depends on the valve or valves affected, the severity of the lesion, and whether complications such as atrial fibrillation have developed.

Exertional Dyspnea

The most common presenting symptom of hemodynamically significant mitral stenosis is exertional dyspnea: shortness of breath that begins with physical activity and progressively occurs at lower levels of exertion as the stenosis worsens. Men may attribute this to being “out of shape,” to weight gain, or to aging. The insidious onset of dyspnea in a condition that progresses over decades means that many men have unconsciously adjusted their activity level downward without recognizing the change.

The pathophysiology of dyspnea in mitral stenosis reflects increased left atrial pressure transmitted back into the pulmonary veins and capillaries, resulting in pulmonary congestion. At rest, cardiac output may be maintained and symptoms may be minimal. With exercise, heart rate rises and the time available for diastolic filling shortens, creating an acute elevation in left atrial pressure that produces dyspnea.

Atrial Fibrillation and Palpitations

Left atrial dilation secondary to mitral stenosis is a powerful driver of atrial fibrillation. In populations with RHD, atrial fibrillation complicates mitral stenosis at high rates, and it can be the presenting manifestation of the underlying valve disease.

A man who develops palpitations, irregular heartbeat, or an acute episode of heart failure may be experiencing new-onset atrial fibrillation attributable to previously unrecognized mitral stenosis. The atrial fibrillation diagnosis may then be treated without the underlying structural cause being identified, particularly if the evaluating physician does not think to order an echocardiogram.

Atrial fibrillation in the context of mitral stenosis carries a particularly high embolic stroke risk because the dilated, dysfunctional left atrium is highly prone to thrombus formation, particularly in the left atrial appendage. The stroke risk in rheumatic mitral stenosis with atrial fibrillation is substantially higher than in non-valvular atrial fibrillation.

Embolic Stroke as a Presenting Event

In some cases, the first clinical manifestation of RHD is an embolic stroke or transient ischemic attack (TIA). The left atrial thrombus, formed in the stagnant, dilated left atrium of a man with unrecognized mitral stenosis, fragments and embolizes to the cerebral circulation.

A man in his 30s or 40s presenting with stroke from an endemic-RHD-region background who is found to have atrial fibrillation without obvious coronary artery disease or other traditional stroke etiologies should have the cardiac anatomy carefully characterized. Echocardiography, including transesophageal echocardiography if transthoracic imaging is inadequate, may reveal mitral stenosis as the underlying structural cause.

Right Heart Failure Symptoms

In advanced or long-standing mitral stenosis, pulmonary hypertension develops as the chronically elevated pulmonary venous pressure drives remodeling of the pulmonary vasculature. Right ventricular pressure rises to match the elevated pulmonary artery pressure, eventually leading to right ventricular dysfunction and right heart failure.

Right heart failure symptoms include peripheral edema (swelling of the legs and ankles), ascites (fluid in the abdomen), and fatigue. These symptoms in a middle-aged man from an RHD-endemic region warrant a cardiac evaluation that explicitly includes valve assessment.

Echocardiographic Findings in RHD

Echocardiography, or cardiac ultrasound, is the diagnostic cornerstone for RHD. It allows direct visualization of valve anatomy and function, measurement of valve areas and pressure gradients, assessment of atrial and ventricular dimensions, and detection of complications including pericardial effusion and pulmonary hypertension.

Classic echocardiographic findings in rheumatic mitral stenosis include:

Thickening and fibrosis of the mitral valve leaflets, with the degree of thickening and calcification captured in the Wilkins or Padial score, which guides decisions about the feasibility of percutaneous intervention. Fusion of the commissures (the junctions between adjacent leaflet tips), which produces the characteristic “hockey stick” or “elbow” appearance of the anterior leaflet in the parasternal long-axis view. Reduced mitral valve area, measured by planimetry or pressure half-time; severe stenosis is typically defined as a valve area below 1.0 square centimeter. Left atrial enlargement, which correlates with the duration and severity of the obstruction. Elevated transmitral pressure gradients on Doppler interrogation of the valve. Pulmonary hypertension, detected by tricuspid regurgitation jet velocity.

How to Advocate for Your Own Evaluation

Men from RHD-endemic regions who have unexplained exertional dyspnea, palpitations, or irregular heart rhythm have specific information that is clinically valuable and that physicians may not think to elicit. Being explicit with your healthcare provider about the following increases the likelihood of appropriate evaluation:

Your country and region of origin. South Asia, Sub-Saharan Africa, Latin America, and Pacific Island regions have substantially higher RHD prevalence than high-income countries. This context is directly relevant to your differential diagnosis.

Whether you had rheumatic fever or repeated strep throat as a child. Many men will not know whether they had rheumatic fever specifically, because the diagnosis may not have been made in their childhood setting. A history of multiple episodes of throat infection with joint pain and fever in childhood is clinically suggestive. So is a history of having been told you had a heart murmur as a child.

Whether you have any known history of valve problems. Some men may have been told about a murmur at some point in their lives and not followed up.

Asking directly whether echocardiography would be appropriate. If you have unexplained dyspnea or palpitations and the origin is not clear, you can ask your physician whether a cardiac ultrasound to look at valve function would add useful information. This is a reasonable question for any patient with cardiovascular symptoms of unclear etiology.

What Happens After Diagnosis

The management of rheumatic heart disease after diagnosis involves a spectrum of interventions that your cardiologist will discuss based on the severity of valve involvement, the presence of complications, and your overall health status.

Secondary prophylaxis, the prevention of recurrent GAS infections to prevent further valve damage, is a cornerstone of RHD management. Your cardiologist or infectious disease physician may discuss penicillin prophylaxis protocols, though the duration and approach vary by age, valve severity, and individual circumstances.

For hemodynamically significant mitral stenosis with favorable valve anatomy, percutaneous mitral balloon valvotomy (PMBV), a catheter-based procedure to open the fused valve leaflets, is a well-established option that your interventional cardiologist may discuss. For valves with severe calcification or significant mitral regurgitation, surgical repair or replacement may be considered.

Atrial fibrillation in the context of RHD requires anticoagulation to reduce stroke risk, and the management of rate control and rhythm in rheumatic mitral stenosis has specific considerations that differ from non-valvular atrial fibrillation. Your cardiologist will guide these decisions.

The Equity Dimension of RHD

Rheumatic heart disease is, at its root, a disease of poverty, crowding, and healthcare access inequality. It has been eliminated in populations that had access to antibiotics and medical care and has been sustained in populations that did not. Men who immigrated from endemic regions carry its legacy not through any personal failure but through the accident of where they grew up and what medical resources were available.

When these men enter healthcare systems in high-income countries, they deserve care that accounts for where they came from. That requires both physician awareness and patient advocacy. The diagnostic delay that commonly affects immigrant men with RHD reflects a failure of systems to adapt to demographic reality, not a failure of the patients themselves.

Speaking up about your background, your symptoms, and your need for evaluation is not demanding too much. It is the appropriate use of a healthcare encounter.

Summary

Rheumatic heart disease is the cardiac legacy of untreated streptococcal infection in childhood, and it remains endemic in South Asia, Sub-Saharan Africa, Latin America, and other regions from which significant immigrant populations have come to high-income countries. Men who grew up in these regions and now present with unexplained exertional dyspnea, palpitations, atrial fibrillation, or embolic stroke should have RHD included in the differential diagnosis and echocardiographic evaluation considered.

The characteristic findings of rheumatic mitral stenosis on echocardiography are distinctive, and the diagnosis, once made, opens a pathway to evidence-based management. The barrier is primarily one of awareness, both among physicians who do not reflexively consider this diagnosis and among patients who do not know to advocate for it. If your background includes a childhood in an RHD-endemic region and you have cardiovascular symptoms without a clear explanation, this is the conversation to have with your physician.

Frequently Asked Questions

Q: How would I know if I had rheumatic fever as a child if it was never diagnosed? A: In many endemic regions, rheumatic fever is not diagnosed because the healthcare infrastructure to do so is unavailable or inaccessible. A history of repeated episodes of throat infection with joint pain and fever in childhood is suggestive, as is being told at any point that you had a heart murmur. Neither is definitive, but either should prompt discussion with your physician about whether echocardiographic screening is appropriate.

Q: Can rheumatic heart disease progress silently without symptoms? A: Yes. The progression from initial valve damage during childhood rheumatic fever to hemodynamically significant stenosis that produces symptoms typically takes decades. Many men carry significant mitral stenosis without symptoms until they reach their 30s or 40s, and some may unconsciously adapt their activity to avoid exertion that triggers symptoms. Echocardiography can detect valve disease before symptoms are recognized.

Q: If I am diagnosed with mitral stenosis from RHD, does that mean I need surgery? A: Not necessarily. The decision to intervene depends on the severity of stenosis, the presence of symptoms, echocardiographic parameters including valve anatomy and pulmonary artery pressure, and your overall health status. Many patients with mild to moderate mitral stenosis are managed with surveillance echocardiography and medical monitoring rather than immediate intervention. Your cardiologist is the appropriate person to discuss the specific options and timing.

Q: Does rheumatic heart disease only affect the mitral valve? A: The mitral valve is the most commonly affected, involved in approximately 65 to 70 percent of cases, but the aortic valve is also frequently affected, either alone or in combination with the mitral valve. Aortic regurgitation is the most common aortic lesion. The tricuspid and pulmonary valves are less commonly involved. Your echocardiogram will characterize which valves are affected in your specific case.

Q: I am from West Africa and have been having palpitations my doctor attributes to “stress.” What should I do? A: Palpitations in a man from an RHD-endemic region warrant a cardiac workup that includes an electrocardiogram and echocardiography, not just reassurance that stress is the cause. You can specifically ask your physician whether an echocardiogram would be appropriate given your background and your symptoms. If your concern is not being taken seriously, requesting a cardiology referral is a reasonable and appropriate step.

The Signal Check is fifteen questions mapping the male cardiovascular risk pattern, including the physiological domains most commonly missed in standard screenings. It produces a specific starting point for your next clinical conversation.